Peptonic Medical and Orion enter VagiVital™ tech transfer agreement
Stockholm, December 21st , 2017 - Peptonic Medical AB (publ) (’Peptonic’ or ’Company’) today announced that it has entered a tech transfer agreement with Orion Corporation, headquartered in Espoo, Finland. Under the agreement, the two companies will exchange information and collaborate to prepare for the commercial manufacture of VagiVital™ - a product that Peptonic plans to launch in 2018. In addition to the tech transfer agreement, the companies have signed a terms sheet for a final agreement regarding the commercial manufacture of VagiVital™. - We are very pleased to have